Journal Article > LetterFull Text
Lancet Global Health. 1 January 2025; Volume 13 (Issue 1); e24.; DOI: 10.1016/S2214-109X(24)00462-5
Lee JSF, Sued O, Ribeiro I, Jarvis JN, Burry J
Lancet Global Health. 1 January 2025; Volume 13 (Issue 1); e24.; DOI: 10.1016/S2214-109X(24)00462-5
Journal Article > ReviewFull Text
Lancet HIV. 1 November 2024; Online ahead of print; DOI:10.1016/S2352-3018(24)00233-9
Cortes CP, Sued O, Wong WCW, Borquez A, Ssonko C, et al.
Lancet HIV. 1 November 2024; Online ahead of print; DOI:10.1016/S2352-3018(24)00233-9
Journal Article > ReviewFull Text
Lancet Global Health. 1 September 2024; Volume 12 (Issue 9); e1552-e1559.; DOI:10.1016/S2214-109X(24)00225-0
Lee JSF, Cohen RM, Khan RA, Burry J, Casas EC, et al.
Lancet Global Health. 1 September 2024; Volume 12 (Issue 9); e1552-e1559.; DOI:10.1016/S2214-109X(24)00225-0
Journal Article > ResearchFull Text
PLOS One. 17 October 2013; Volume 8 (Issue 10); DOI:10.1371/journal.pone.0077697
Fenner L, Ballif M, Graber C, Nhandu V, Dusingize JC, et al.
PLOS One. 17 October 2013; Volume 8 (Issue 10); DOI:10.1371/journal.pone.0077697
In resource-constrained settings, tuberculosis (TB) is a common opportunistic infection and cause of death in HIV-infected persons. TB may be present at the start of antiretroviral therapy (ART), but it is often under-diagnosed. We describe approaches to TB diagnosis and screening of TB in ART programs in low- and middle-income countries.